A patient feels cold for a few days after a tirzepatide (Zepbound) injection; what should I advise?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Feeling Cold After Zepbound is Not a Recognized Side Effect

Reassure the patient that feeling cold is not a documented adverse effect of tirzepatide (Zepbound), but evaluate for alternative explanations including metabolic complications, dehydration from gastrointestinal side effects, or unrelated illness.

Understanding the Side Effect Profile

The most common side effects of tirzepatide are gastrointestinal: nausea (occurring in 25% of patients), vomiting, and diarrhea (each in up to 10% of patients) 1. Feeling cold is not listed among the recognized adverse effects in current guidelines or FDA labeling.

What to Evaluate

Rule Out Metabolic Complications

While rare, serious metabolic disturbances have been reported with tirzepatide:

  • Check for hypoglycemia: Even in non-diabetic patients, tirzepatide can cause low blood sugar, which may present with cold sensations, fatigue, and other symptoms 2
  • Assess for ketoacidosis: Though uncommon, tirzepatide-induced ketoacidosis has been documented, presenting with vomiting, fatigue, and metabolic disturbances 2
  • Consider dehydration: If the patient has experienced nausea, vomiting, or diarrhea, dehydration could cause cold intolerance

Assess GI Side Effects

Ask specifically about:

  • Nausea, vomiting, or diarrhea (which could lead to dehydration and electrolyte imbalances)
  • Adequate fluid and food intake
  • Abdominal pain (which could indicate more serious complications like pancreatitis or biliary disease) 1

Check for Rare Serious Complications

If the patient has additional concerning symptoms:

  • Severe abdominal pain: Could indicate pancreatitis or biliary disease 1
  • Muscle pain or dark urine: Rhabdomyolysis has been reported, though extremely rare 3
  • Worsening symptoms: May warrant liver function testing, as hepatotoxicity has been documented 4

Practical Management Approach

  1. Take vital signs: Check temperature, blood pressure, and heart rate
  2. Obtain point-of-care glucose: Rule out hypoglycemia immediately
  3. Review hydration status: Assess for signs of volume depletion
  4. Ask about concurrent symptoms: Fever, infection, or other systemic illness unrelated to tirzepatide

Common Pitfalls to Avoid

  • Don't automatically attribute every symptom to the medication—feeling cold for several days may represent an intercurrent illness
  • Don't overlook dehydration from GI side effects, which is a more plausible explanation than a direct drug effect
  • Don't dismiss the complaint, as it could be an early sign of metabolic disturbance requiring laboratory evaluation

When to Escalate

Obtain laboratory testing (glucose, electrolytes, ketones, creatine kinase) if:

  • The patient has concurrent vomiting, severe fatigue, or abdominal pain
  • Signs of dehydration are present
  • Symptoms are progressive or severe

If basic evaluation is unremarkable and the patient is otherwise well, reassure them that this is not a typical medication side effect and monitor for resolution or development of other symptoms that would warrant further investigation.

Related Questions

What is the next step in management for a non‑diabetic patient on tirzepatide who has been vomiting for 12 hours despite receiving IV fluids, ondansetron, diphenhydramine, and famotidine?
In a 69-year-old man who recently increased tirzepatide (Zepbound) from 10.5 mg to 12.5 mg, could the higher dose be causing his dizziness and fatigue?
Could Zepbound (tirzepatide) be causing dehydration and orthostatic tachycardia in a 69-year-old Black male?
What is the appropriate evaluation and management for an 82-year-old male taking tirzepatide (Monjaro) 7.5 mg weekly who presents with muscle weakness, low energy, fatigue, and poor oral intake?
In a 53‑year‑old male on tirzepatide (Mounjaro) 2.5 mg for three months who has a weight‑loss plateau, exercise‑related fatigue, a history of hiatal hernia, recurrent nephrolithiasis, dyslipidemia, and labs showing elevated homocysteine, micro‑albuminuria, low‑normal testosterone, and LDL ≈ 115 mg/dL, what management steps should be taken?
How often can I increase the dose of Thorazine (chlorpromazine)?
What is the most effective topical cream for treating hypertrophic or atrophic scars?
Which injectable medication can cause marked chills and a feeling of being very cold for a few days after administration?
What is the recommended treatment for tendinitis?
What is the appropriate management for a spider bite to the face in an adult male?
In an elderly patient with dementia who is only on citalopram 10 mg daily, is very medication‑sensitive and small in size, what is the safest as‑needed (PRN) medication for anxiety or agitation that avoids strong benzodiazepines such as lorazepam?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.